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Abstract. Generating anatomically realistic three-dimensional (3D) models of the
human sinonasal cavity for numerical investigations of sprayed drug transport presents
a host of methodological ambiguities. For example, subject-specific radiographic
images used for 3D reconstructions typically exclude spray bottles. Subtracting a
bottle contour from the 3D airspace and dilating the anterior nasal vestibule for
nozzle placement augment the complexity of model-building. So, we explored the
question: how essential are these steps to adequately simulate nasal airflow and
identify the optimal delivery conditions for intranasal sprays? In particular, we
focused on particle deposition patterns in the maxillary sinus, a critical target site
for chronic rhinosinusitis (CRS). The models were reconstructed from post-surgery
computed tomography scans for a 39-year-old Caucasian male, with CRS history.
Inspiratory airflow patterns during resting breathing are reliably tracked through CFD-
based steady state laminar-viscous modeling and such regimes portray relative lack of
sensitivity to inlet perturbations. Consequently, we hypothesized that the posterior
airflow transport and the particle deposition trends should not be radically affected
by the nozzle subtraction and vestibular dilation. The study involved 1 base model
and 2 derived models; the latter two with nozzle contours (two different orientations)
subtracted from the dilated anterior segment of the left vestibule. We analyzed spray
transport in the left maxillary sinus for multiple release conditions. Similar release
points, localized on an approximately 2mm-by-4.5mm contour, facilitated improved
maxillary deposition in all three test cases. This suggests functional redundancy of
nozzle insertion in a 3D numerical model for identifying the optimal spray release
locations.
Keywords: Computational fluid dynamics (CFD); nasal sprays; chronic rhinosinusitis;
sinonasal modeling; clinical engineering; topical drug delivery
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1. Introduction
Therapeutics for chronic rhinosinusitis (CRS) constitutes a layered approach1–4
comprising oral antibiotics, anti-inflammatory drugs, and surgical intervention, along
with topical medications like nasal sprays. The anatomical alteration through surgery
does not always address the inflammation from CRS, while long-term use of antibiotics
and anti-inflammatory medications comes with systemic side-effects. Consequently,
topical nasal sprays may represent a viable component of medical therapy for CRS.
There is, however, a caveat as the topical sprays do not always ensure an optimum drug
delivery to the affected areas of the sinonasal cavity. Of interest is hence to identify the
different spray parameters and application techniques that would maximize the topical
deposition of the drugs in critical areas like the maxillary and the ethmoid sinuses (see
Figure 1 for these anatomical landmarks). The techniques entail the head positions,
nozzle positions, and breathing methods that would maximize the target site particle
deposition (TSPD). While in vivo measurements of drug delivery is an ambitious idea,
computational fluid dynamics (CFD) simulations of nasal spray intake promise a feasible
preliminary path towards identification of the optimal spray techniques.
Investigations through the CFD route incorporate the following three basic steps:
(1) acquiring the patient-specific computed tomography (CT) scans of the sinonasal
cavity, (2) developing an in silico three-dimensional (3D) sinonasal model based on
the CT scans using an image-processing software package, and creating a mesh of the
flow domain for numerical simulations, (3) CFD analysis of the meshed model using
numerical discretization techniques. Step (3) outputs the topical deposition of the
medicated particles by tracking the flow patterns and the particle trajectories. To run
a reliable simulation, it might seem essential to insert a nozzle into the 3D model in
step (2) and edit the model by subtracting the nozzle contour from the nasal airspace,
along with dilating the lateral walls to account for nozzle placement. The tip of the
nozzle would indicate the starting point of the nasal spray particle transport. However,
the patient-specific scans typically exclude any nozzle, and insertion of a nozzle at the
image-processing stage involves an elaborate superficial reshaping of the anterior nasal
cavity lining. There is no conclusive evidence in literaturee.g. 5–9 on the variability of the
CFD-based modeling strategy to identify the optimal nasal spray instructions, based on
whether the spray nozzle is accounted for or not in the CT-based 3D reconstructions.
However, a preliminary study10 in one normal subject suggested that the regional
particle deposits were largely unaffected by the nozzle presence.
To address the above ambiguity related to the 3D modeling protocol, our study
presents a comparison of the TSPD trends of nasal spray particles in three different test
models (1 base model and 2 additional derived models) developed from the CT scans of
the same patient. The models differed only at the anterior part of the nasal cavity at
the left nostril. Model I (base model; see Figure 2(a)) did not include any nozzle, while
Model II and Model III (see panels (b) and (c) in Figure 2) included spray bottles with
two very different nozzle orientations (subtracted from the internal airspace), while still
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Figure 1: (a) A representative CT imaging slice of the subject’s sinonasal cavity, after a bilateral functional endoscopic
sinus surgery. The section is anterior to the iatrogenic zone. Panel (b) depicts the coronal view and panel (c) presents
the sagittal view of the anatomically realistic 3D reconstruction of the sinonasal cavity from the CT scans. The different
sinonasal chambers are marked.
making sure that the spray directions conformed to the clinical safety guidelines.
Nasal airflow for resting breathing has been evidenced to be predominatly
laminar,11–13 implying that the flow features are less sensitive to the inlet-zone
perturbations resulting from the nozzle insertion in the anterior nasal vestibule. Thus,
we hypothesized that the posterior airflow transport and consequently the sprayed
particle depostion patterns in the three models should be relatable, which would in turn
suggest redundacy of nozzle insertion in the numerical models while trying to identify
the optimal spray release conditions. To check this hypothesis, we conducted particle
simulations for a wide array of release points in the left nasal airspace and compared
the locations for improved topical deposition in the left maxillary sinus (LMS) across
the three test models.
Preliminary reports on this work have been presented at the annual meetings of
the American Physical Society (APS) – Division of Fluid Dynamics.14,15
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2. Methods
2.1. Patient selection
This methods study was implemented under the approval of the Institutional Review
Board (IRB) committee at the University of North Carolina at Chapel Hill. It is part
of an ongoing more extensive investigation16 by our group to identify the optimal spray
techniques and breathing methods for improved topical deposition of medicated aerosol
particles, using the tools of CFD, supplemented by in vitro experimental findings.
We are targeting a final cohort recruitment of 30 CRS patients. The acquired CT
scans, before and after functional endoscopic sinus surgery (FESS), would be used to
develop 3D models for CFD-based explorations. In order to ensure a homogeneous study
population, we only include patients without polyps and with the sinus disease confined
primarily to the ostiomeatal complex (OMC) region. For the current study, we have
used de-identified CT scans from a 39-year-old Caucasian male (weighing 94.5 kg with
height 72 inches), who had a bilateral FESS for the treatment of medically recalcitrant
CRS, without nasal polyps.
2.2. Generating the base sinonasal model (Model I)
Anatomically realistic 3D reconstruction of the sinonasal airspace was developed
from the post-operative CT scan images imported into the medical imaging software
package MimicsTM 18.0 (Materialize, Inc., Plymouth, MI, USA) in Digital Imaging
and Communications in Medicine (DICOM) file format. The scans consisted of 270
slices, taken at depth increments of 0.399 mm, with a pixel size of 0.4 mm. An image
radiodensity threshold range of -1024 to -300 Hounsfield units17 was used to delineate the
nasal airways and the paranasal sinuses from the medical-grade CT scans, followed by
careful hand-editing of the selected pixels to achieve anatomic accuracy. The sinonasal
geometries were exported in stereolithography (STL) file format to the computer-aided
design and meshing software ICEM-CFDTM 15.0 (ANSYS, Inc., Canonsburg, PA, USA),
where the 3D reconstruction was finalized in an XYZ cartesian space. For convenience,
all the geometries were re-oriented in ICEMTM to render the nasal floor parallel to
the Z-axis. For the airspace boundaries: (1) planar surfaces were added spanning
the outer rims of the nostrils, (2) a 2-cm outlet tube was added to the posterior end
of the nasopharynx to ensure a fully-developed outlet flow and was closed off by a
planar surface. The airspace was meshed using approximately four million unstructured,
graded tetrahedral elements with three layers of 0.1 mm prism elements extruded at the
air-tissue boundary. We performed a mesh quality analysis to minimize the number
of distorted low-quality elements, which could hinder the accuracy of the numerical
simulations. Furthermore, as evidenced in literature18 through a sensitivity analysis on
the average pressure at the posterior septum and on the outlet flow, four million graded
tetrahedral elements in the base computational mesh are sufficient to achieve robust
and grid-independent numerical solutions. To finalize the meshing protocol, we further
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Figure 2: (a) Model I (base model) reconstructed from the CT scans. Panels (b) and (c) show the derived models
(Model II and Model III, respectively). In (b) and (c), the red contours comprise the nozzle-subtracted airspace and
represent two different nozzle orientations. Panel (d) demonstrates the real nozzle contour that was subtracted from the
base model airspace to generate Models II and III, each with a different angular orientation of the nozzle.
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Figure 3: (a) The white line on the sinonasal base model (Model I) illustrates a representative cross-sectional cut. (b)
Representative visual of the meshed model along the cut from panel (a). The mesh consists of 4 million unstructured,
graded tetrahedral elements along with three layers of 0.1 mm prism cells extruded at the cavity-tissue interfaces. (c)
Inset : A representative zoomed-in snapshot of the boundaries with the prism layers. Background color was inverted for
better visualization. These figures were generated on the postprocessing software package FieldViewTM 16 (Intelligent
Light, Lyndhurst, PA).
referenced our recent work19 which has suggested that localized mesh refinement (on top
of the base tetrahedral mesh with four million elements) in the sinuses is not essential
for these simulations, based on an aymptotic analysis of inward and outward airflow
ratio across the antrostomy window. This sinonasal model constituted the base model,
referred to as Model I in the present study.
2.3. Creating additional sinonasal models – Model II and Model III:
A 3D printer was used to print Model I in two compartments: (1) the anterior
compartment, made from a flexible material, comprising the external nares and nasal
vestibule; and (2) the posterior compartment comprising the rest of the sinonasal airway
and made from a rigid material. CT imaging of the flexible anterior compartment with
a nasal spray bottle inserted through the left nostril was used to generate a 3D rendition
of the assembly in MimicsTM. The spray bottle reconstruction was then virtually
repositioned by aiming it toward the back of the nose in accordance to the package
guidelines20 for commonly prescribed nasal steroid spray products, and the nozzle was
subsequently subtracted from the distended vestibular airspace. On the ICEM-CFDTM
platform, this distended anterior chunk was separated from the new model and replaced
into a copy of Model I, from which the same left anterior undistended region had already
been taken out. We developed two such derived models: Model II with an upward
inclined spray axis and Model III with a downward inclined spray axis. Lowest panels
in Figures 2 (b) and (c) provide visual distinction between the two contrasting nozzle
orientations, when seen from the sagittal direction. These derived models were meshed
following the same protocol as discussed above in Section 2.2. Note that to maximize
inter-model comparability, the models were kept identical except at the anterior half of
the left nasal vestibule, where we had the nozzle insertion.
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Figure 4: Safe spray release points are extracted from Model I. The X axis points in the sagittal direction, the Z axis
points in the coronal direction, and the Y axis points perpendicularly upward from the hard floor of the palate in the
axial direction. Each individual spray release axis is directed from the centroid of the nostril plane (marked by the tiny
dark square) to the corresponding release point. Panels (a) and (b) show the release contour. Panel (c) demonstrates
all 43 probable release points and directions. Panel (d) sagittally lays out the clinically inadvisable directions. The 16
clinically safe release conditions are in panel (e).
2.4. Setting out the feasible release points for the nasal spray
Figure 4 lays out the lattice orientation of 43 potential spray release points inside the
left nasal vestibule. The contour was so selected as to mark the physical limits for
comfortable nozzle placement. These points were all equidistant from the centroid of
the planar inlet surface that covered the left nostril in the 3D model and at a depth of 1
cm from it. The angular location of these points covered a swept region of 75◦ to 30◦ to
the horizontal. For Model I, the direction vectors for spray axis were calculated from the
centroid of the left nostril plane to the corresponding release point. Of the 43 probable
spray release points identified, the points for which the release directions were hitting
the septum in the base model (Model I), within a depth of 2 cm from the centroid of the
left nostril plane, were considered to be clinically “unsafe”. This is reasoned based on
the intranasal spray guidelines20 which suggest pointing the spray nozzle in the direction
of the lateral nasal wall and away from the septum. The criterion precluded 16 release
points in the current lattice from further consideration, and particle tracking simulations
were performed using the remaining 27 “safe” spray directions. Note that in Models II
and III, each spray axis was directed from the centroid of the area-outline on the left
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Figure 5: Lognormal distribution of the particulate droplet sizes in the FlonaseTM spray for a single shot weight of
100 mg. The total number of particles in one shot, as per the particle size distribution (PSD) with 5 µm size bins, was
estimated to be 343,968. The particles were all assumed to be spherical in shape and of unit density. WS represents one
shot weight.
nostril plane where the nozzle contour intersects it, to the corresponding release point.
2.5. Characteristics of the topical nasal spray
For a realistic nasal spray transport and deposition in our CFD simulations, over-the-
counter FlonaseTM Allergy Relief was selected as the spray to be numerically tracked
for this study; it being one of the most commonly prescribed nasal sprays. Four units
of FlonaseTM were sent to Next Breath, LLC (Baltimore, MD, USA) to test the in vitro
spray performance. The findings gave us the droplet size distribution as measured by
laser diffraction using a Malvern Spraytec STP2000 and plume geometry as analysed
by a SprayVIEW NOSP, which is a non-impaction laser sheet-based instrument. The
mean spray half cone angle was observed to be 31.65◦, and the droplet sizes were found
to follow a log-normal distribution. The probability density function, with x being the
droplet diameter, was of the form:
f(x) =
1√
2pix lnσg
exp
[
−(lnx− lnx50)
2
2(lnσg)2
]
. (1)
Here x50 = 37.16 µm is the volume mean diameter, or in other words, exp(x50) is
the median of the lognormal distribution.21 Also, σg = 2.08 is the geometric diameter
(geometric standard deviation), or in other words, lnσg is the standard deviation S, with
S2 =
∑n
i=1[ln(xi− x¯)]2/(n− 1), where n is the total number of particulate droplets and
x¯ = (
∑n
i=1 lnxi) /n. The distribution of the particulates with respect to their diameters
is shown in Figure 5. With droplet sizes ranging from 5 to 525 µm in aerodynamic
diameter (with size bin increments of 5 µm) and assuming them to be spherical and
of unit density, the total number of droplets in one shot weight of WS = 100 mg
quantified to 343,968. While simulating the particle trajectories in the CFD software
package FluentTM 14.5 (ANSYS, Inc., Canonsburg, PA, USA), we assumed solid-cone
type injections. Furthermore, for the mean spray exit velocity, we used 19.2 m/s based
on phase doppler anemometry-based measurements in literature22 for FlonaseTM.
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2.6. Solution schemes for the inspiratory flow dynamics and the nasal spray
trajectories
For an incompressible fluid, the principle of mass conservation (continuity) necessitates
∇ · u = 0, (2)
with u being the fluid velocity vector. At steady state, the conservation of linear
momentum leads to the modified Navier-Stokes equations:
ρ (u · ∇) u = −∇p+ µ∇2u + ρb, (3)
where, in the current system, ρ = 1.204 kg/m3 is the air density, µ = 1.825 × 10−5
kg/m.s is the dynamic viscosity of air, p is the incumbent pressure, and b represents
the body accelerations like gravity (g), inertial accelerations etc. Airflow simulations
were performed by numerically solving the differential equations 2 and 3 using FluentTM
through a finite volume approach, under laminar conditions in the inspiratory direction.
Justification for assuming flow-laminarity emerged from experimental evidences13 which
suggested that nasal airflow belongs to the laminar regime at comfortable resting
breathing rates. Also, since our simulation explored a single cycle of inspiration, steady
state flow conditions were surmised to be a good approximation for resting breathing.
The numerical solution employed the following boundary conditions: (1) zero velocity
at the air-tissue interfaces (no slip at the walls, with “trap” boundary conditions for the
particle tracking); (2) zero pressure at the nostril planes which acted as the pressure-
inlet zones (with “reflect” boundary conditions for particle tracking); and (3) a negative
outlet pressure (with “escape” boundary conditions for particle tracking) commensurate
to the inhalation airflow rate based on the subject-specific allometric scaling. Such
equations, V˙ = 1.36M0.44 for males (sitting awake) and V˙ = 1.89M0.32 for females
(sitting awake), have been derived in published literature23 for a healthy cohort, with V˙
being the minute volume in liters per minute and M being the body mass in kilograms.
The formulation (for male cohort) was judged applicable for the current post-operative
subject owing to an assumed similarity of breathing patterns between non-symptomatic
healthy people and post-operative CRS patients without nasal polyps. The solution
scheme employed a segregated solver, based on SIMPLEC pressure-velocity coupling
and second-order upwind spatial discretization. Numerical convergence was determined
through minimizing the residuals (mass continuity∼ 10−2, velocity components∼ 10−4),
and by stabilizing the mass flow rate and the static pressure at the outlet.
Particle transport was simulated through the series of solid-cone injections
emanating from the laid out release points (see Section 2.4), with the spray
characteristics as discussed in Section 2.5. Separate particle tracking simulations were
performed for each of the 27 safe release points and the respective TSPD at the LMS
were compared to identify the optimal release zones. The simulations were based on
a Discrete Phase Model (DPM) in FluentTM, in which Lagrangian particle tracking
was used to estimate the individual trajectories by integrating the particle transport
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Figure 6: Representative streamlines from the numerical airflow simulations in: (a) Model I, (b) Model II, and (c) Model
III. Panels (b) and (c) additionally demonstrate the nozzle placement, corresponding to the nozzle contours that have
been subtracted (along with the inclusion of dilated nares) from the nasal airspace in the two derived models. The grey
background shows the tissue domain lining the sinonasal cavity. These figures were generated using the postprocessing
software package FieldViewTM, after import of the numerical solutions from FluentTM.
equations through the Runge-Kutta method:
dup
dt
= FD(u− up) + g ρp − ρ
ρp
+ Fi, (4)
with up being the particle velocity, u being the airflow field velocity, ρp and ρ being
the particle and air densities respectively, g being the gravitational acceleration, and Fi
being the additional forces per unit particle mass, like Saffman lift force contribution
owing to the lift exerted by a flow-shear field on small particles perpendicular to the
direction of flow. FD(u− up) is the drag force per unit particle mass, with
FD =
18µ
ρpd2p
CDR
24
, (5)
where µ is the dynamic viscosity of air, dp is the particle diameter, CD is the drag
coefficient on a smooth spherical particle,24 and R is the relative Reynolds number,
calculated as R = ρdp|up − u|/µ.
The solution scheme considered the particulate droplets to be large enough to ignore
any possible effects of Brownian motion on their dynamics. Spray particle simulations
were conducted five times for each release point in all three models, to account for
the variability of the FluentTM-based DPM solver in assigning random initial directions
to the sprayed particles in the solid-cone injections. The topical particle deposition
numbers in the LMS were expressed in terms of the deposited mass fraction (DMF)
percentage, which was calculated as
DMF =
WLMS
WS
× 100, (6)
where WLMS was the net weight of the particulate droplets deposited in the LMS in
each simulation run. To gauge the statistical significance of the congruity of the TSPD
patterns in the three test models, we ran Spearman’s rank-order test on the particle
deposits at the LMS in each model and examined the rank correlation between the
three sets of paired groups drawn from the test models.
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Table 1: Steady state inpiratory flow rates (= 2×minute volume) in Liters/min in the numerical simulations.
Allometric target Model I Model II Model III
20.13 20.0 20.17 20.15
Variation from target −0.65% +0.20% +0.10%
2.6.1. Monitoring possible regime transition in the nasal airflow: Vigorous air-intake
during sniffing or higher respiratory demands during exercise can mobilize sinonasal
flows to devolve into turbulence. However, at resting to moderate breathing rates (≤ 25
L/min), more streamlined laminar airflow conditions are found to prevail.11–13 For a
consistent basis to identify the flow regime, we looked at Reynolds numbers in the three
models. The dimensionless Reynolds number (Re), which is a ratio of the convective
inertia of the flow to its viscosity, can be calculated25 as Re = ρ v Dh/µ, where ρ is
the air density, v is the airflow speed, Dh = 4×(cross-sectional area)/(wetted perimeter
at the cross-section) is the hydraulic diameter for irregular cross-section, and µ is the
dynamic viscosity of air. In the airflow simulations, we measured Re at the cross-section
where the anterior segment from Model I was replaced by the nozzle-subtracted contours
to generate Models II and III (see Figure 2). The nasal cavity widened beyond that
region, resulting in the Re locally peaking close to that cross-section; it being directly
proportional to the flow-rate which is, in turn, inversely related to the cross-sectional
passage area transverse to the generic flow direction. Such a threshold choice helped us
to monitor any possible transition to turbulent behavior as the Re peaked.
3. Results
3.1. Topical deposition of the nasal spray
Effectivity of a topical medication to treat CRS critically centers on whether the sprayed
particles can penetrate through to the typically remote sinonasal chambers, like the
maxillary or the ethmoid sinuses. To compare the airflow and particle simulation results
in the three models: we representatively collated the TSPD data in the LMS for the
spray that was administered through the left nasal airspace in all the models. With
respect to an allometric target of 20.13 Liters/min (see Section 2.6 for the predictive
formulation; also see Table 1), the laminar steady state flow simulations were converged
at ≤ |1%| error and returned inspiratory breathing rates of 20.0 Liters/min in Model I,
20.17 Liters/min in Model II, and 20.15 Liters/min in Model III.
3.2. Justification for the laminar idealization based on Reynolds numbers
The Re in Model I was 1945, followed by 1991 and 1989 in Models II and III,
respectively. The anterior nasal flow can be idealized as a pipe flow and there is a
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Figure 7: Bar diagram of the spray mass fractions deposited in the LMS in the three test models. The numbers on the
horizontal axis indicate the corresponding identifiers of the spray release locations, based on their assigned nomenclature
in FluentTM. The same number in all the models corresponds to the same release location. The error bars represent
the maximum and minimum deposits from the five particle tracking simulation runs implemented for each spray release
point.
deluge of experimental as well as numerical work in the applied mechanics literature
on the flow transition in such systems. Under constant pressure gradient,26 turbulent
“puffs” appeared at Re ≈ 2800, with slugs (trapped bubbles resulting in two-phase flow)
emerging beyond Re ≈ 3000. For constant flow rates,27 fully-developed turbulence was
seen beyond Re ≈ 2700. The airflow in our models can hence be assumed to adhere to a
predominantly laminar profile, with some probable transitional features. In this context,
we noted that while the flow patterns (see Figure 6) demonstrated vortex formations,
there are enough evidencese.g. 28–32 suggesting that a flow with such rotational patterns
can still preserve laminarity. As a numerical idealization, implementing the laminar
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Figure 8: Panels (a), (b), and (c) show the topical deposition patterns at the LMS in Models I, II, and III respectively.
The height of the red spike at each release point is proportional to the deposited mass fraction corresponding to that
spray release location. The spike heights have been proportionally standardized with the peak deposit in each model
being represented by a 5 mm tall spike. Direction vectors of the spikes are oriented from the centroid of the nostril (in
Model I) and from the centroid of the nozzle base on the nostril plane (in Models II and III) to the corresponding release
point. These centroids are illustrated in the three pictorial representations by a small dark circle. The letter “S” marks
the septal side. Panel (d) shows the sectional cut through which the depictions in (a), (b), and (c) were visualized. The
“bubble-diagrams” in panels (e), (f), and (g) show an alternate visual representation of the same information. Here the
release contour has been projected on the XZ plane, roughly parallel to the floor of the palate. The bubble sizes are
proportional to the LMS deposit corresponding to the release location whose projection is the center of that bubble. The
color scheme was so chosen that the findings for the same release point have the same color, in all three models. Note
the unsafe release points were marked by the tiny hollow circles. We identified a small optimal zone for the best-possible
spray release points and the ellipse (drawn with the dashed line) roughly demarcated that zone. For scaled representation,
its size is compared to the US quarter-dollar coin.
modeling framework was thus deemed justified.
3.3. Congruity of deposition patterns in the three models
Figure 7 plots the mass fraction of spray particles deposited in the LMS for each of the
27 safe release points (see Section 2.4 for details on the spray release points and release
contour). Based on the numerical identity of the release points (along the horizontal
axis in Figure 7), the deposition patterns, in terms of the peak and plateau zones, were
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Figure 9: Color maps of the velocity magnitude of the inspired airflow field across six different cross-sections (c/s-1
to c/s-6). See the top-most panel for the cross-sections selected. Left-right orientation of the graphics in each of the
flow profile panels respectively corresponds to the left and right sides of the study subject. The flow patterns observed
on c/s-1 noticeably demonstrate the fluctuations from nozzle placement (in Models II and III) in the anterior vestibule.
Stagnation zones closely posterior to the nozzle tips are demarcated by the black circles. Flow profiles display increasing
conformity at larger penetration depths.
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Figure 10: Graphical representation of the power of the sample with respect to the sample size. The latter, in this
case, is the number of numerical runs implemented for particle tracking corresponding to each release point. These
representative power curves were traced out for the release location 1 in all the three test models.
congruous for the three models, with the optimal release points still localized in the
same areas of the release contour. In this context, Figures 8(a)–(c) demonstrate an
alternate view with the extruded spikes at each release point denoting the quantity of
LMS deposits as well as the direction vector of the original spray. In Figures 8(e)–(g),
we projected the release contour on to the XZ plane (parallel to the floor of the hard
palate) and traced a “bubble-diagram” with the incrementing circle sizes representing
proportionally higher topical deposits at the LMS, with the center of each circle being
the projection of the corresponding release point. Note that the color schematic in
Figures 8(e)–(g) is such that the same release point has the same color in the three
planar projections. A small optimal zone for the best-possible spray release points was
identified and it was the same in all the test models. An ellipse (drawn with the dashed
line), spanning roughly over a 2mm-by-4.5mm contour, was drawn to demarcate that
zone in the “bubble-diagrams”.
For a statistical check of the congruity of TSPD patterns with respect to the release
locations, we ran the Spearman’s rank correlation test over three different selections of
paired groups (Models I and II, Models I and III, and Models II and III) with respect to
the corresponding LMS deposits. For each model, the test ranked the deposits from the
different release points according to their magnitudes and then assessed how well these
rank-orders correlate between two different models. For the comparison between Models
I and II, the test returned R = 0.929, with the two-tailed p < 0.000001. For Models I
and III, we had R = 0.866, with the two-tailed p < 0.000001. For Models II and III, the
test gave R = 0.767, with the two-tailed p < 0.000003. Thus, the congruity of deposition
patterns across the three test models could be considered statistically significant.
3.3.1. Varying penetration of spray particles in the three models: There was a caveat
in terms of the absolute quantities of topical deposition. The peak deposit of 0.92%
spray mass fraction in Model I was more than five times the peak deposit (0.18% spray
mass fraction) in Model II; reason being larger anterior deposits in the latter. However,
Model I and Model III presented somewhat similar peak deposits, with the latter offering
0.94% spray mass fraction. The deposited particle sizes ranged from 5 to 40 µm.
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3.4. Variability of the numerical results for spray deposition
The spray simulations were run 5 times for each release point, in each of the Models
I, II, and III. We performed sample size analysis in each model to calculate the power
of detecting a significant difference so that our mean deposition mass fraction based
on the 5 simulation runs would lie within a margin (say, x) of error of 5% of the peak
mass deposition fraction in the LMS. Thus, for Model I, x = 0.00045; for Model II,
x = 0.00009; and for Model III, x = 0.00047. Simultaneously, the level of significance,
which is the probability of rejecting the hypothesis when it is true (Type I error),
was set at 0.05. With further inputs of the mean and the standard deviations of the
deposited mass fractions; the power of the test, which quantifies the probability of
correctly rejecting the hypothesis when it is false, came out to be very close to 1.0 in
each model, when averaged over the spray release points. Specifically, the mean powers
were 0.98 in Model I, 0.93 in Model II, and 0.96 in Model III. Hence, in terms of number
of simulation trials at each release point, the study was considered detailed enough with
a sufficiently broad sample size to ensure statistical reproducibility. This implementation
scheme also conformed to previously published statistical benchmarking.33
Table 2: Mean mass fraction deposits at the left maxillary sinus, based on 5 runs, along with the corresponding standard
deviations. Left-most column indicates the spray release point identifiers.
Rel.
Pt.
Model I Model II Model III
Mass fraction Standard deviation Mass fraction Standard deviation Mass fraction Standard deviation
3 0.00529 0.000127279 0.0009984 0.0000294669 0.003818 0.000216032
4 0.004678 0.000176833 0.001082 0.0000363318 0.00288 0.000112472
5 0.008526 0.000140285 0.0009966 0.0000875717 0.005278 0.0000834865
6 0.006098 0.000110995 0.001812 0.000107564 0.004156 0.0000988939
7 0.006236 0.0000328634 0.001392 0.0000641872 0.004344 0.0000867756
8 0.003834 0.000281034 0.000224 0.0000260096 0.005174 0.000127201
13 0.00266 0.000162635 0.0000861 0.0000190164 0.003658 0.000127554
14 0.001896 0.0000673053 0.0001612 0.0000119038 0.00496 0.000293002
15 0.003342 0.000127945 0.0002386 0.0000203052 0.009408 0.000335738
16 0.000357 0.0000175642 0.0000379 0.00000257196 0.000831 0.0000677237
17 0.0002654 0.0000656415 0.0000236 0.00000651038 0.00153 0.000121037
18 0.00002524 0.0000133129 0.000007196 0.00000193154 0.001154 0.0000947629
19 0.00010984 0.0000362876 0.00000783 0.00000432576 0.001432 0.0000952365
20 0.0005118 0.0000802322 0.000016644 0.00000599314 0.001952 0.00014025
21 0.0007564 0.0000371053 0.000037 0.00000955693 0.002732 0.0000960208
22 0.000027158 0.0000131633 0.000008688 0.00000149655 0.0010216 0.0000763891
23 0 – 0.00000485 0.00000397665 0.0002336 0.0000124218
24 0 – 0.000007704 0.0000031044 0.0001592 0.0000117558
27 0 – 0 – 0.0004008 0.0000281727
28 0 – 0.00000183152 0.0000013478 0.0007478 0.0000187003
29 0 – 0 – 0.0002794 0.0000307782
30 0.0001037 0.0000289418 0 – 0.0003976 0.0000254224
31 0.00007694 0.0000139414 0.00001854 0.00000485829 0.0004614 0.0000478571
33 0.001952 0.0000903881 0.00009594 0.0000158248 0.003846 0.000199324
34 0.009186 0.000258225 0.0004806 0.00000585662 0.00803 0.000433359
37 0.004022 0.0000491935 0.001252 0.0000334664 0.002088 0.0000593296
38 0.002024 0.0000522494 0.0006216 0.0000299717 0.000858 0.0000256515
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4. Discussion
We explored methodological ambiguities related to the inclusion of a spray bottle inside
the anterior nasal vestibule of a 3D computational reconstruction, in the context of
numerically ascertaining the optimal spray release locations for improved topical drug
delivery. Three test models were developed: one base model without nozzle subtraction
and two additional derived models with two very different orientations of subtracted
nozzle from the nasal airspace (along with laterally dilated anterior vestibule to account
for nozzle insertion), developed from the post-surgical CT scans of the same subject
with a history of CRS. We performed inspiratory airflow simulations under steady state
conditions in these three models. Sprayed particle transport was then numerically
tracked for a lattice of 27 clinically safe nasal spray directions. The optimal zone
for spray release for better drug penetration to the maxillary sinus (a crucial target
site for treating CRS) stayed the same in all three models. The flow features were
such that they could be reliably modeled within a laminar framework. Hence, the
congruous TSPD patterns in the three cases supported our key hypothesis that laminar
airflow regimes, being dictated by the geometric macro-scales, would be less sensitive
to the inlet perturbations (pertaining to the nozzle placement zone) thereby hardly
affecting the posterior airflow transport and particle deposition trends. The optimal
spray release zone (see Figure 8) was rather tiny and covered a roughly 2mm-by-4.5mm
elliptical contour in all three test models. The results thus indicate a redundancy of
nozzle insertion (i.e. subtracting the nozzle contour from the nasal vestibule) for such
3D anatomic reconstructions.
There are however some points of critique connected to the study design and
assumptions, examined hereunder:
• Reduction of the inspiratory airflow in resting human breathing to a steady state
laminar profile, while being a good approximation for the brief single-cycle span
during which the sprayed particles propagate through the sinonasal cavity, is still
an idealization. Inspiration and expiration demonstrably have some acceleratory
and deceleratory components. However, our preliminary forays and other existing
findings34 on time-dependent simulations have until now yielded results in agreement
with the steady state framework assumed for resting breathing.
• The three models differed only in the anterior portion (refer back to Figure 2) of the
left nasal airspace. Model I was built from the subject-specific CT scans, while Models
II and III had the anterior portions built from scans of a 3D printed model (of Model
I) with a spray nozzle inserted at the left nostril. To compare between the models,
care was taken that apart from this nozzle placement zone, the computational subject-
specific reconstructions stayed analogous and comparable. However, note should be
made that the subtle geometrical effects of the nozzle placement on the nasal lining
may extend beyond this anterior chunk, based on subject-specific variations in tissue
pliability.
• Topical deposits at the (left) maxillary sinus were miniscule and less than 1% spray
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mass fraction. The TSPD also differed between the three test models (for details, see
Sections 3.3 and 3.3.1). Such variations between numerical models with and without
the spray nozzle are in agreement with published results.8 However, the core aim of
our study was to explore if nozzle subtraction and vestibular dilation were essential
to identify the release points which would allow for the best possible sinonasal target
site deposition. Thus, the absolute quantities of deposits were not of any compelling
relevance and we focused more on the pattern of targeted deposition with respect to
the lattice of spray release locations.
• While quantifying the drug transport to the target sinonasal sites (in this study, the
LMS), we have assumed that the sprayed particles get trapped on the internal cavity
walls (mimicking the tissue surfaces), without any further mucus drainage transport
or escape probabilities. This is an idealized assumption at this stage, and it would
be interesting to capture the nuances beyond the scope of these current limitations.
Nasal mucus is essentially non-Newtonian in terms of its physical properties and this
makes modeling its viscosity challenging.35 In this context, the reader may refer to
a recent CFD-based study9 investigating the effects of mucociliary clearance on drug
uptake in the human nasal cavity (excluding the paranasal sinuses). Also see36 for a
particularly interesting account (albeit not for respiratory flows) on the complex fluid
dynamical subtleties associated with other classes of biological flows.
• We assumed that the particles in motion never had any kinematic interactions with
the other sprayed particles during their sinonasal transport. Nor was there any effect
of the partcles’ motion on the ambient inspiratory airflow. Additionally, their material
density, sizes, and spherical shapes stayed unchanged as they propagated through the
nasal cavity.
Despite these caveats, this methods study, to summarize, does make the important
suggestion that vestibular nozzle insertion in a 3D nasal model is not essential for re-
liable airflow simulations, particularly while identifying the optimal release conditions
for targeted delivery of sprayed intranasal drugs. The inference alleviates the process of
reconstructing anatomically realistic sinonasal models from patient-specific CT imaging.
The findings will provide an important functional tool towards using 3D computational
modeling on large cohorts of patient scans, which can help in recommending new usage
instructions for aerosolized sprays aimed at maximizing particulate transport and de-
position at the nasal target sites, hence providing a more effective therapeutic care for
diseases like chronic rhinosinusitis.
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